SIBN

SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use

SI-BONE, Inc. Announces the Introduction of the SI-BONE SImulator™ Powered by Medability for iFuse Surgeon Training and Education

French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.'s iFuse-3D Implant System™

SI-BONE to Present at the 2021 JMP Securities Life Sciences Conference

SI-BONE, Inc. (SIBN) CEO Laura Francis on Q1 2021 Results - Earnings Call Transcript

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Recap: SI-BONE Q1 Earnings